Yamamoto Kazuhiro 山本和宏

… Alternative Names

YAMAMOTO KAZUHIRO 山本和宏

Less

Researcher Number	30610349
Other IDs
Affiliation (Current)	2025: 岡山大学, 医歯薬学域, 教授
Affiliation (based on the past Project Information) *help	2024 – 2025: 岡山大学, 医歯薬学域, 教授 2020 – 2024: 神戸大学, 医学部附属病院, 講師 2019: 神戸大学, 医学部附属病院, 講師(若手枠) 2018: 神戸大学, 医学部附属病院, 特命講師 2013 – 2017: 神戸大学, 医学部附属病院, 薬剤師 2012 – 2013: 神戸大学, 医学部附属病院, その他
Review Section/Research Field	Principal Investigator Medical pharmacy / Basic Section 47060:Clinical pharmacy-related Except Principal Investigator Basic Section 58020:Hygiene and public health-related: including laboratory approach / Medium-sized Section 58:Society medicine, nursing, and related fields / Basic Section 47060:Clinical pharmacy-related / Medical pharmacy
Keywords	Principal Investigator STAT3 / 分子標的治療薬 / 上皮間葉転換 / mTOR / エベロリムス / EMT / mTOR阻害薬 / 間質性肺疾患 / 皮膚障害 / データベース … More / CKD / everolimus / ILD / SNP / ゲノム薬理 / 間質性肺炎 / 分子標的治療医薬 / マルチキナーゼ阻害薬 / 治療法 / 手足皮膚反応 / 克服法 / HFSR / ソラフェニブ / HaCaT / 角化細胞 / 手足症候群 … More Except Principal Investigator ハイブリッドスクリーニング / 機械学習 / ゼブラフィッシュ / バイオマーカー / 免疫関連有害事象 / 免疫チェックポイント阻害薬 / 心筋炎 / 薬物動態 / PBPK / ファーマコメトリクス / 周産期 / パリペリドン / リスペリドン / 乾燥ろ紙血 / LC-MS/MS / 抗精神病薬 / 生理学的薬物動態モデル / 新生児 / 妊婦 / AMPK / SNAT3 / P110 / 4EBP1 / eIF4E / p-4EBP1 / ZNF512B / Raptor / mTORC1 / 妊娠 / 栄養感知システム / mTOR / 安全性学 / 医薬品情報学 / 食品栄養学 / 医療薬学 / 胎盤栄養素輸送 Less

Development of a high-throughput screening method to overcome both drug resistance and adverse effects in cancer pharmacotherapy
- Principal Investigator
  
  座間味義人
- Project Period (FY)
  2025 – 2028
- Research Category
  
  Grant-in-Aid for Scientific Research (B)
- Review Section
  
  Basic Section 58020:Hygiene and public health-related: including laboratory approach
- Research Institution
  Okayama University
データベーススクリーニングを活用した慢性腎臓病の新規治療標的の探索Principal Investigator
- Principal Investigator
  
  山本和宏
- Project Period (FY)
  2024 – 2026
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Kobe University
Prediction of Immune Checkpoint Inhibitor-Induced Myocarditis through Integrated Analysis of Real-World Data and Genomics
- Principal Investigator
  
  座間味義人
- Project Period (FY)
  2024 – 2027
- Research Category
  
  Fund for the Promotion of Joint International Research (International Collaborative Research)
- Review Section
  
  Medium-sized Section 58:Society medicine, nursing, and related fields
- Research Institution
  Okayama University
周産期母児における抗精神病薬治療の適正化のためのファーマコメトリクス
- Principal Investigator
  
  矢野育子
- Project Period (FY)
  2022 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Kobe University
Strategy for prevention of interstitial lung disease induced by molecular targeted therapy.Principal Investigator
- Principal Investigator
  
  Yamamoto Kazuhiro
- Project Period (FY)
  2019 – 2021
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 47060:Clinical pharmacy-related
- Research Institution
  Kobe University
Integrated research for clarification of molecular biological and pharmacogenomic mechanisms of interstitial lung disease induced by molecular targeted drugsPrincipal Investigator
- Principal Investigator
  
  Yamamoto Kazuhiro
- Project Period (FY)
  2016 – 2018
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kobe University
Searching for treatment and prevention method of molecular targeted drugs-induced dermatological side effects based on the pathological mechanismPrincipal Investigator
- Principal Investigator
  
  YAMAMOTO KAZUHIRO
- Project Period (FY)
  2014 – 2015
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kobe University
The role of the mTOR signalling pathway in placental nutrient transport.
- Principal Investigator
  
  HIRANO TAKESHI
- Project Period (FY)
  2013 – 2015
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Research Field
  
  Medical pharmacy
- Research Institution
  Health Sciences University of Hokkaido
  Kobe University
Search for biomarkers of adverse events as skin reaction by molecular target drugsPrincipal Investigator
- Principal Investigator
  
  YAMAMOTO KAZUHIRO
- Project Period (FY)
  2012 – 2013
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Medical pharmacy
- Research Institution
  Kobe University

All 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Other

All Journal Article Presentation Book

[Book] 医薬ジャーナル2012年9月号2012
- Author(s)
  山本和宏,平野剛,平井みどり
- Publisher
  医薬ジャーナル社
- Data Source
  KAKENHI-PROJECT-24790156
[Journal Article] Pharmacokinetics of Brexpiprazole, Quetiapine, Risperidone, and Its Active Metabolite Paliperidone in a Postpartum Woman and Her Baby2024
- Author(s)
  Konishi Toru、Kitahiro Yumi、Fujiwara Naoko、Yamamoto Kazuhiro、Hashimoto Mari、Ito Takahiro、Itohara Kotaro、Fujioka Kazumichi、Imafuku Hitomi、Otsuka Ikuo、Omura Tomohiro、Yano Ikuko
- Journal Title
  
  Therapeutic Drug Monitoring
  
  Volume: - Issue: 5 Pages: 687-691
- DOI
  10.1097/ftd.0000000000001197
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K06697
[Journal Article] Physiologically‐based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate2023
- Author(s)
  Mahdy Walaa Y. B.、Yamamoto Kazuhiro、Ito Takahiro、Fujiwara Naoko、Fujioka Kazumichi、Horai Tadasu、Otsuka Ikuo、Imafuku Hitomi、Omura Tomohiro、Iijima Kazumoto、Yano Ikuko
- Journal Title
  
  Clinical and Translational Science
  
  Volume: 16 Issue: 4 Pages: 618-630
- DOI
  10.1111/cts.13473
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-22K06697
[Journal Article] Upfront use of first-/second-generation EGFR-TKI followed by osimertinib shows better prognosis than upfront osimertinib therapy in Japanese patients with non-small-cell lung cancer with exon 19 deletion: A single-center retrospective study.2023
- Author(s)
  Hori T, Yamamoto K, Ito T, Ikushima S, Omura T, Yano I
- Journal Title
  
  Biol. Pharm. Bull
  
  Volume: -
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K06697
[Journal Article] ALBI Grade Is a Predictive Factor of Lenvatinib Treatment Discontinuation due to Adverse Events in Hepatocellular Carcinoma2023
- Author(s)
  ENOMOTO DAICHI、YAMAMOTO KAZUHIRO、MATSUMOTO YUKI、MORIOKA ASAMI、OMURA TOMOHIRO、KOMATSU SHOHEI、YANO YOSHIHIKO、FUKUMOTO TAKUMI、YANO IKUKO
- Journal Title
  
  Anticancer Research
  
  Volume: 43 Issue: 3 Pages: 1317-1323
- DOI
  10.21873/anticanres.16279
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-22K06697
[Journal Article] Association ofSTAT3, CYP3A5, andABCG2Polymorphisms With Osimertinib-induced Adverse Events in NSCLC Patients2023
- Author(s)
 TANDA MASAAKI、YAMAMOTO KAZUHIRO、HORI TOMOKI、NISHIGUCHI HIROKI、YAGI MIKI、SHIMIZU MICHIKO、KONISHI TORU、OZAKI TOMONORI、YOSHIOKA NATSUE、TACHIHARA MOTOKO、ITO TAKEFUMI、IKUSHIMA SHIGEKI、OMURA TOMOHIRO、YANO IKUKO
- Journal Title
 
 Anticancer Research
 
 Volume: 43 Issue: 4 Pages: 1775-1783
- DOI
 10.21873/anticanres.16331
- Peer Reviewed / Open Access
- Data Source
 KAKENHI-PROJECT-22K06697, KAKENHI-PROJECT-20K08518
[Journal Article] STAT3 polymorphism associates with mTOR inhibitor-induced interstitial lung disease in patients with renal cell carcinoma2022
- Author(s)
  Kazuhiro Yamamoto, Takeshi Ioroi, Kazuaki Shinomiya, et al.
- Journal Title
  
  Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
  
  Volume: - Issue: 1 Pages: 11-23
- DOI
  10.3727/096504022x16418911579334
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K07191, KAKENHI-PROJECT-19K07219, KAKENHI-PROJECT-20K09560
[Journal Article] ゲノム医療の発展と薬剤師の役割2019
- Author(s)
  山本和宏
- Journal Title
  
  Apo Talk
  
  Volume: 65 Pages: 2-4
- Data Source
  KAKENHI-PROJECT-19K07191
[Journal Article] Genetic polymorphisms associated with adverse reactions of molecular-targeted therapies in renal cell carcinoma2018
- Author(s)
  Yamamoto Kazuhiro、Yano Ikuko
- Journal Title
  
  Medical Oncology
  
  Volume: 35 Issue: 2 Pages: 16-16
- DOI
  10.1007/s12032-017-1077-0
- NAID
  120006649621
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] Association of CYP2D6 polymorphisms and extrapyramidal symptoms in schizophrenia patients receiving risperidone: a retrospective study.2018
- Author(s)
  Ito T, Yamamoto K, Ohsawa F, Otsuka I, Hishimoto A, Sora I, Hirai M, Yano I.
- Journal Title
  
  Journal of Pharmaceutical Health Care and Sciences
  
  Volume: 4 Issue: 1 Pages: 28-28
- DOI
  10.1186/s40780-018-0126-y
- NAID
  120006543322
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-17H04249, KAKENHI-PROJECT-16K08400, KAKENHI-PROJECT-16K08401, KAKENHI-PROJECT-16K19765
[Journal Article] シグナル伝達因子に起因する間質性肺炎発症メカニズム2018
- Author(s)
  山本和宏，中川勉，矢野育子，平井みどり
- Journal Title
  
  メディカル・サイエンス・ダイジェスト
  
  Volume: 44 Pages: 49-53
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] Association of Expression Levels or Activation Status of STAT3 with Treatment Outcomes of Sunitinib in Patients with Renal Cell Carcinoma.2018
- Author(s)
  Yamamoto K., Hara T., Nakagawa T., Hirai M., Miyake H., Fujisawa M., Yano I.
- Journal Title
  
  Targeted Oncology
  
  Volume: 13 Issue: 3 Pages: 371-378
- DOI
  10.1007/s11523-018-0563-4
- NAID
  120006649622
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K01820, KAKENHI-PROJECT-16K08401
[Journal Article] Association of the PCK2 Gene Polymorphism With New-onset Glucose Intolerance in Japanese Kidney Transplant Recipients2018
- Author(s)
  Yokoyama N.、Ishimura T.、Oda T.、Ogawa S.、Yamamoto K.、Fujisawa M.
- Journal Title
  
  Transplantation Proceedings
  
  Volume: 50 Issue: 4 Pages: 1045-1049
- DOI
  10.1016/j.transproceed.2018.01.042
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] 腎臓病薬物療法専門薬剤師の活動と挑戦（編集委員会発トピックス）2018
- Author(s)
  山本和宏
- Journal Title
  
  日本腎臓病薬物療法学会誌
  
  Volume: 7 Pages: 215-217
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] Basic examination of the electrochemiluminescence immunoassay (ECLIA) method for measuring everolimus blood concentrations2018
- Author(s)
  大籔智奈美、佐藤伊都子、東口佳苗、山本和宏、石村武志、中町祐司、三枝淳
- Journal Title
  
  Japanese Journal of Medical Technology
  
  Volume: 67 Issue: 5 Pages: 722-726
- DOI
  10.14932/jamt.18-39
- NAID
  130007501067
- ISSN
  0915-8669, 2188-5346
- Year and Date
  2018-10-25
- Language
  Japanese
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] Effects of Ascorbyl-2-phosphate Magnesium on Human Keratinocyte Toxicity and Pathological Changes by Sorafenib2017
- Author(s)
  Yamamoto K., Shichiri H., Ishida T., Kaku K., Nishioka T., Kume M., Makimoto H., Nakagawa T., Hirano T., Bito T., Nishigori C., Yano I., Hirai M.
- Journal Title
  
  Biological and Pharmaceutical Bulletin
  
  Volume: 40 Issue: 9 Pages: 1530-1536
- DOI
  10.1248/bpb.b17-00386
- NAID
  130006038784
- ISSN
  0918-6158, 1347-5215
- Language
  English
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K01820, KAKENHI-PROJECT-16K08401
[Journal Article] 「薬剤師外来」における薬学的処方介入とその評価2017
- Author(s)
  栗村朋子，山本和宏，池田剛久，橋本正良，西岡達也，久米学，槇本博雄，矢野育子，平井みどり
- Journal Title
  
  医療薬学
  
  Volume: 43 Pages: 169-175
- NAID
  130006470917
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] Potentially inappropriate medications in elderly Japanese patients: effects of pharmacists' assessment and intervention based on Screening Tool of Older Persons' Potentially Inappropriate Prescriptions criteria ver.2.2017
- Author(s)
  Kimura T, Ogura F, Yamamoto K, Uda A, Nishioka T, Kume M, Makimoto H, Yano I, Hirai M
- Journal Title
  
  J Clin Pharm Ther.
  
  Volume: 42 Issue: 2 Pages: 209-214
- DOI
  10.1111/jcpt.12496
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401, KAKENHI-PROJECT-17H00562
[Journal Article] Compatibility and Stability of Nab-Paclitaxel in Combination with Other Drugs.2017
- Author(s)
  Mizuta Naomi、Nakagawa Tsutomu、Yamamoto Kazuhiro、Nishioka Tatsuya、Kume Manabu、Makimoto Hiroo、Yano Ikuko、Minami Hironobu、Hirai Midori
- Journal Title
  
  Kobe Journal of Medical Sciences
  
  Volume: 63
- NAID
  120006329054
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients2017
- Author(s)
 Watanabe A., Yamamoto K., Ioroi T., Hirata S., Harada K., Miyake H., Fujisawa M., Nakagawa T., Yano I., Hirai M.
- Journal Title
 
 Biological and Pharmaceutical Bulletin
 
 Volume: 40 Issue: 4 Pages: 458-464
- DOI
 10.1248/bpb.b16-00875
- NAID
 130005530145
- ISSN
 0918-6158, 1347-5215
- Language
 English
- Peer Reviewed
- Data Source
 KAKENHI-PROJECT-16K01820, KAKENHI-PROJECT-16K08401
[Journal Article] Prostaglandin E1 reduces the keratinocyte toxicity of sorafenib by maintaining signal transducer and activator of transcription 3 (STAT3) activity and enhancing the cAMP response element binding protein (CREB) activity.2017
- Author(s)
  Shichiri H., Yamamoto K., Tokura M., Ishida T., Uda A., Bito T., Nishigori C., Nakagawa T., Hirano T., Yano I., Hirai M.
- Journal Title
  
  Biochemical and Biophysical Research Communications
  
  Volume: 485 Issue: 2 Pages: 227-233
- DOI
  10.1016/j.bbrc.2017.02.107
- NAID
  120006733140
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K01820, KAKENHI-PROJECT-16K08401
[Journal Article] 薬剤師による処方設計〈61〉薬剤師主導のバンコマイシン処方設計に向けた取り組み2017
- Author(s)
  住吉霞美，山本和宏，矢野育子
- Journal Title
  
  医薬ジャーナル
  
  Volume: 53 Pages: 131-135
- NAID
  40021357274
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] 分子標的治療薬による皮膚障害のSTAT3を標的とした新規治療法の確立2017
- Author(s)
  山本和宏
- Journal Title
  
  薬学研究の進歩
  
  Volume: 33 Pages: 115-120
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] ゾピクロン錠とエスゾピクロン錠の苦味比較（第2報）‐ランダム化二重盲検クロスオーバー試験‐2017
- Author(s)
  宇田篤史, 大澤史宜, 山本和宏, 四宮一昭, 平野剛, 平井みどり
- Journal Title
  
  日本病院薬剤師会雑誌
  
  Volume: 53 Pages: 192-196
- NAID
  120006784499
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] マルチキナーゼ阻害薬による皮膚障害におけるSTAT3の役割2017
- Author(s)
  山本和宏
- Journal Title
  
  医療薬学
  
  Volume: 43 Pages: 237-244
- NAID
  130006733804
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] シグナル伝達因子に起因する間質性肺炎発症メカニズム2017
- Author(s)
  山本和宏、中川勉、矢野育子、平井みどり
- Journal Title
  
  別冊Bio Clinica
  
  Volume: 6 Pages: 121-125
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-16K08401
[Journal Article] Association of Single Nucleotide Polymorphisms in STAT3 with Hand-Foot Skin Reactions in Patients with Metastatic Renal Cell Carcinoma Treated with Multiple Tyrosine Kinase Inhibitors: A Retrospective Analysis in Japanese Patients.2016
- Author(s)
  Yamamoto K., Shinomiya K., Ioroi T., Hirata S., Harada K., Suno M., Nishioka T., Kume M., Makimoto H., Nakagawa T., Hirano T., Bito T., Nishigori C., Miyake H., Fujisawa M., Hirai M.
- Journal Title
  
  Targeted Oncology
  
  Volume: 11 Issue: 1 Pages: 93-99
- DOI
  10.1007/s11523-015-0382-9
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26750041, KAKENHI-PROJECT-26860104
[Journal Article] STAT3 polymorphism rs4796793 may be a predictive factor of tumor response to multiple tyrosine kinase inhibitors in metastatic renal cell carcinoma in Japanese population.2016
- Author(s)
  Yamamoto K., Ioroi T., Kanaya K., Shinomiya K., Komoto S., Hirata S., Harada K., Watanabe A., Suno M., Nishioka T., Kume M., Makimoto H., Nakagawa T., Hirano T., Miyake H., Fujisawa M., Hirtai M.
- Journal Title
  
  Medical Oncology
  
  Volume: 33 Issue: 3 Pages: 24-24
- DOI
  10.1007/s12032-016-0733-0
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26750041, KAKENHI-PROJECT-26860104
[Journal Article] Induction of epithelial-mesenchymal transition via activation of epidermal growth factor receptor contributes to sunitinib resistance in human renal cell carcinoma cell lines.2015
- Author(s)
  Mizumoto A., Yamamoto K., Nakayama Y., Takara K., Nakagawa T., Hirano T., Hirai M.
- Journal Title
  
  Journal of Pharmacology and Experimental Therapeutics
  
  Volume: 355 Issue: 2 Pages: 152-158
- DOI
  10.1124/jpet.115.226639
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26750041, KAKENHI-PROJECT-26860104
[Journal Article] Apoptotic Effects of the Extracts of Cordyceps militaris via Erk Phosphorylation in a Renal Cell Carcinoma Cell Line.2015
- Author(s)
  Yamamoto K., Shichiri H., Uda A., Yamashita K., Nishioka T., Kume M., Makimoto H., Nakagawa T., Hirano T., Hirai M.
- Journal Title
  
  Phytotherapy Research
  
  Volume: 25 Issue: 5 Pages: 707-713
- DOI
  10.1002/ptr.5305
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26750041, KAKENHI-PROJECT-26860104
[Journal Article] Apoptotic Effects of the Extracts of Cordyceps militaris via Erk Phosphorylation in a Renal Cell Carcinoma Cell Line.2015
- Author(s)
  Yamamoto K, Shichiri H, Uda A, Yamashita K, Nishioka T, Kume M, Makimoto H, Nakagawa T, Hirano T, Hirai M
- Journal Title
  
  Phytotherapy Research
  
  Volume: in press
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-26860104
[Journal Article] Association of toxicity of sorafenib and sunitinib for human keratinocytes with inhibition of signal transduction and activator of transcription 3 (STAT3).2014
- Author(s)
  2.Yamamoto K., Mizumoto A., Nishimura K., Uda A., Mukai A., Yamashita K., Kume M., Makimoto H., Bito T., Nishigori C., Nakagawa T., Hirano T., Hirai M.
- Journal Title
  
  PLoS One
  
  Volume: 9 Issue: 7 Pages: e102110-e102110
- DOI
  10.1371/journal.pone.0102110
- NAID
  120005465541
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-26750041, KAKENHI-PROJECT-26860104
[Journal Article] 患者のジェネリック医薬品変更希望に影響を及ぼす患者背景・重要因子の探索-ジェネリック医薬品の適切な使用促進のために-2013
- Author(s)
  四宮一昭,池方康一郎,小山敏広,山本和宏,平野剛,北村佳久,平井みどり,千堂年昭
- Journal Title
  
  日本薬剤師会雑誌
  
  Volume: 65 Pages: 23-25
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24790156
[Journal Article] Everolimus-induced human keratinocytes toxicity is mediated by STAT3 inhibition2013
- Author(s)
  Yamamoto K, Uda A, Mukai A, Yamashita K, Kume M, Makimoto H, Bito T, Nishigori C, Hirano T, Hirai M
- Journal Title
  
  J Exp Clin Cancer Res
  
  Volume: 32 Pages: 83-83
- NAID
  120005462472
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-24790156
[Journal Article] Everolimus-induced human keratinocytes toxicity is mediated by STAT3 inhibition.2013
- Author(s)
  Kazuhiro Yamamoto, Atsushi Uda, Akira Mukai, Kazuhiko Yamashita, Manabu Kume, Hiroo Makimoto, Toshinori Bito, Chikako Nishigori, Takeshi Hirano, Midori Hirai
- Journal Title
  
  Journal of Experimental & Clinical Cancer Research
  
  Volume: 32 Issue: 1 Pages: 1-10
- DOI
  10.1186/1756-9966-32-83
- NAID
  120005462472
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] Physiologically-based pharmacokinetic modeling and simulation of fentanyl for treatment optimization in neonates.2023
- Author(s)
  Yamamoto K, Mahdy WYB, Hashimoto M, Hasegawa M, Nakasone R, Fujioka K, Itohara K, Kitahiro Y, Omura T, Yano I
- Organizer
  The 21st International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2023)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K06697
[Presentation] 免疫チェックポイント阻害薬投与患者の好中球リンパ球比による層別化とプロトンポンプ阻害薬の併用による生命予後への影響2023
- Author(s)
  堀智貴，山本和宏，伊藤武文，生島繁樹，大村友博，矢野育子
- Organizer
  日本臨床腫瘍薬学会学術大会2023
- Data Source
  KAKENHI-PROJECT-22K06697
[Presentation] 非小細胞肺がん患者におけるオシメルチニブの有害事象に関する薬理遺伝学的解析2023
- Author(s)
  丹田雅明，山本和宏，堀智貴，西口大生，八木美樹，清水倫子，小西徹，尾崎智規，吉岡奈津恵，立原素子，伊藤武文，生島繁樹，大村友博，矢野育子
- Organizer
  日本薬学会第143年会
- Data Source
  KAKENHI-PROJECT-22K06697
[Presentation] ブレクスピプラゾール，クエチアピンおよびリスペリドンを服用中の妊婦とその児における薬物動態の評価2023
- Author(s)
  小西徹，北廣優実，藤原尚子，山本和宏，糸原光太郎，大村友博，矢野育子
- Organizer
  第45回日本病院薬剤師会近畿学術大会
- Data Source
  KAKENHI-PROJECT-22K06697
[Presentation] Effects of pregnancy and renal ontogeny on risperidone/paliperidone pharmacokinetics predicted by physiologically based pharmacokinetic model2022
- Author(s)
  Yamamoto K, Mahdy WYB, Ito T, Fujiwara N, Fujioka K, Horai T, Otsuka I, Imafuku H, Omura T, Iijima K, Yano I
- Organizer
  The 20th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-22K06697
[Presentation] 分子標的型抗がん薬による副作用の分子メカニズムに基づく新規予防戦略の構築2022
- Author(s)
  山本和宏
- Organizer
  日本薬学会142年会
- Invited
- Data Source
  KAKENHI-PROJECT-19K07191
[Presentation] Effects of long-term multiple immunosuppressants on everolimus pharmacokinetics in patients after renal transplantation2022
- Author(s)
  Tomoyuki Sakaue, Kazuhiro Yamamoto, Takahito Endo, Takeshi Ishimura, Masato Fujisawa, Tomohiro Omura, Ikuko Yano
- Organizer
  第32回医療薬学会年会
- Data Source
  KAKENHI-PROJECT-22K06697
[Presentation] Challenges in the optimization of kidney disease therapy by Nephrology and Pharmacotherapy Specialists2021
- Author(s)
  Kazuhiro Yamamoto
- Organizer
  第31回日本医療薬学会年会
- Invited
- Data Source
  KAKENHI-PROJECT-19K07191
[Presentation] 薬剤師が知っておきたいゲノムと薬のはなし2020
- Author(s)
  山本和宏
- Organizer
  千葉病院薬剤師会スキルアップセミナー
- Invited
- Data Source
  KAKENHI-PROJECT-19K07191
[Presentation] よくわかる腎機能低下患者の抗がん薬個別化投与設計2020
- Author(s)
  山本和宏
- Organizer
  第14回日本腎臓病薬物療法学会学術集会・総会
- Invited
- Data Source
  KAKENHI-PROJECT-19K07191
[Presentation] 最新のPGx研究： STAT3遺伝子多型と分子標的型抗がん薬の副作用2019
- Author(s)
  山本和宏
- Organizer
  第29回日本医療薬学会年会
- Data Source
  KAKENHI-PROJECT-19K07191
[Presentation] 経口分子標的型抗がん薬のTDM2019
- Author(s)
  山本和宏
- Organizer
  第41回日本病院薬剤師会近畿学術大会
- Data Source
  KAKENHI-PROJECT-19K07191
[Presentation] Population pharmacokinetic modeling of everolimus in renal transplant patients with multiple immunosuppressive therapy.2019
- Author(s)
  8.Tomoyuki Sakaue, Kazuhiro Yamamoto, Takahito Endo, Takeshi Ishimura, Tomohiro Omura, Ikuko Yano
- Organizer
  日本薬物動態学会　第34回年会
- Data Source
  KAKENHI-PROJECT-19K07191
[Presentation] Role of STAT3 in hand-foot skin reaction induced by multi-targeted tyrosine kinase inhibitors2019
- Author(s)
  Kazuhiro Yamamoto
- Organizer
  日本薬物動態学会　第34回年会
- Invited
- Data Source
  KAKENHI-PROJECT-19K07191
[Presentation] 肺由来細胞のエベロリムス反応性におけるSTAT3遺伝子多型の影響2019
- Author(s)
  浜崎美月，山本和宏，濵口常男，國正淳一，矢野育子
- Organizer
  医療薬学フォーラム2019　第27回クリニカルファーマシーシンポジウム
- Data Source
  KAKENHI-PROJECT-19K07191
[Presentation] がん分子標的治療による副作用の分子メカニズムの解明と克服法の確立に向けた病院薬剤師の挑戦2018
- Author(s)
  山本和宏
- Organizer
  日本薬学会第138年会
- Invited
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] エベロリムス長期曝露肺胞上皮細胞の上皮間葉転換に寄与するケモカインの探索2018
- Author(s)
  岩間弓奈，山本和宏，濵口常男，中川勉，矢野育子
- Organizer
  医療薬学フォーラム2018　第26回クリニカルファーマシーシンポジウム
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] 個別化医療のいまとこれからを考える　-がんゲノム医療からプライマリ・ケアまで-2018
- Author(s)
  山本和宏
- Organizer
  第28回日本医療薬学会年会
- Invited
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] エルロチニブによる皮膚障害におけるアクアポリン3の発現変動2017
- Author(s)
  小野ひとみ，山本和宏，七里博章，渡邉愛未，中川勉，矢野育子，尾藤利憲，錦織千佳子，平井みどり
- Organizer
  日本薬学会第137年会
- Place of Presentation
  仙台
- Year and Date
  2017-03-25
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] 分子標的治療薬の適正使用に向けた遺伝子多型解析の実践2017
- Author(s)
  山本和宏
- Organizer
  第11回日本緩和医療薬学会年会
- Invited
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] Association of Single Nucleotide Polymorphisms in STAT3, ABCB1, and ABCG2 with Stomatitis in Patients with Metastatic Renal Cell Carcinoma Treated with Sunitinib: A Retrospective Analysis in Japanese Patients2017
- Author(s)
  Watanabe A, Yamamoto K, Ioroi T, Hirata S, Harada K, Miyake H, Fujisawa M, Nakagawa T, Yano I, Hirai M
- Organizer
  The 5th International Symposium of Training Plan for Oncology Professionals
- Place of Presentation
  Osaka
- Year and Date
  2017-03-11
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] Bench-to-bedside research for the dermatological side effects induced by multiple tyrosine kinase inhibitors2017
- Author(s)
  Kazuhiro Yamamoto
- Organizer
  The 15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2017)
- Invited / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] エベロリムスによる間質性肺疾患発症メカニズムにおけるTGF-βの関与2017
- Author(s)
  穐原裕奈，山本和宏，渡邉愛未，七里博章，中川勉，濱口常男，矢野育子，平井みどり
- Organizer
  日本薬学会第137年会
- Place of Presentation
  仙台
- Year and Date
  2017-03-25
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] 腎細胞癌患者のスニチニブ治療効果に及ぼす組織STAT3発現の影響2017
- Author(s)
  山本和宏，劉兵，原琢人，渡邉愛未，西岡達也，久米学，槇本博雄，中川勉，矢野育子，三宅秀明，藤澤正人，平井みどり
- Organizer
  日本薬学会第137年会
- Place of Presentation
  仙台
- Year and Date
  2017-03-25
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] Molecular cornifying mechanisms of multi-targeted tyrosine kinase inhibitors-induced hand-foot skin reaction based on genetic differences of STAT32017
- Author(s)
  Kazuhiro Yamamoto, Takahiro Ishida, Tsutomu Nakagawa, Tatsuya Nishioka, Manabu Kume, Hiroo Makimoto, Hideaki Miyake, Masato Fujisawa, Chikako Nishigori, Ikuko Yano, Midori Hirai
- Organizer
  The 15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2017)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] mTOR阻害薬によるトリグリセリド合成亢進作用におけるACAA2の役割2017
- Author(s)
  渡邉愛未，山本和宏，中川勉，矢野育子，平井みどり
- Organizer
  日本薬学会第137年会
- Place of Presentation
  仙台
- Year and Date
  2017-03-25
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] Impact of STAT3 genetic polymorphism on sunitinib-induced stomatitis in Japanese renal cell carcinoma patients2017
- Author(s)
  Aimi Watanabe, Kazuhiro Yamamoto, Takeshi Ioroi, Sachi Hirata, Kenichi Harada, Hideaki Miyake, Masato Fujisawa, Tsutomu Nakagawa, Ikuko Yano, Midori Hirai
- Organizer
  The 15th International Congress of Therapeutic Drug Monitoring & Clinical Toxicology (IATDMCT 2017)
- Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] 学会発表の次のステップ～エビデンスとして残すために～2017
- Author(s)
  山本和宏
- Organizer
  第 1 回医療薬学教育セミナー
- Invited
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] ゲノム情報活用支援システムの有用性の評価と課題2017
- Author(s)
  山本和宏
- Organizer
  第27回日本医療薬学会年会
- Invited
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] 分子標的治療薬の有効性・副作用とSTAT3遺伝子多型の関連2017
- Author(s)
  山本和宏
- Organizer
  第15回日本臨床腫瘍学会学術集会
- Invited
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] 分子標的治療薬の適正使用に向けた現場実践型研究の推進－病院薬剤師の挑戦と責務－2016
- Author(s)
  山本和宏
- Organizer
  日本病院薬剤師会東北ブロック第6回学術大会
- Place of Presentation
  福島
- Year and Date
  2016-05-21
- Invited
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] 分子標的治療薬の副作用に関連したゲノム情報活用における現状と課題（仮）2016
- Author(s)
  山本和宏
- Organizer
  第26回日本医療薬学会年会
- Place of Presentation
  京都
- Year and Date
  2016-09-17
- Invited
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] 分子標的治療薬の適正使用に向けた現場実践型研究の推進－病院薬剤師の挑戦と責務－2016
- Author(s)
  山本和宏
- Organizer
  日本病院薬剤師会東北ブロック第6回学術大会
- Place of Presentation
  福島
- Year and Date
  2016-05-22
- Invited
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] 奨励賞受賞講演：腎細胞がんに対する分子標的治療薬の有効性・副作用予測因子に関する研究2016
- Author(s)
  山本和宏
- Organizer
  第26回日本医療薬学会年会
- Place of Presentation
  京都
- Year and Date
  2016-09-17
- Invited
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] 遺伝子情報を実践的に活用するための連携体制の構築に向けた動向と課題2016
- Author(s)
  山本和宏
- Organizer
  第26回日本医療薬学会年会
- Place of Presentation
  京都
- Year and Date
  2016-09-17
- Invited
- Data Source
  KAKENHI-PROJECT-16K08401
[Presentation] ソラフェニブによる皮膚障害に対するPGE１を用いた治療への応用2015
- Author(s)
  土倉麻弥，山本和宏，中川勉，尾藤利憲，錦織千佳子，濱口常男，平野剛，平井みどり
- Organizer
  日本薬学会第135年会
- Place of Presentation
  神戸
- Year and Date
  2015-03-26
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] 分子標的治療薬による副作用におけるSTAT3遺伝子多型の関連性2015
- Author(s)
  山本和宏，五百蔵武士，四宮一昭，河本紫帆，須野学，平田佐智，中川勉，平野剛，原田健一，三宅秀明，藤澤正人，平井みどり
- Organizer
  第1回日本ゲノム薬理学会学術集会
- Place of Presentation
  神戸
- Year and Date
  2015-02-14
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] 腎細胞癌における分子標的薬の治療効果とSTAT3遺伝子多型との関連性2015
- Author(s)
  河本紫帆，山本和宏，平田佐智，三宅秀明，藤澤正人，田村麻衣，小山敏広，四宮一昭，中川勉，平野剛，平井みどり
- Organizer
  日本薬学会第135年会
- Place of Presentation
  神戸
- Year and Date
  2015-03-26
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] エルロチニブによる痤瘡様皮疹モデルの確立と分子機構の解明2015
- Author(s)
  久土智也，山本和宏，中川勉，尾藤利憲，錦織千佳子，濱口常男，平野剛，平井みどり
- Organizer
  日本薬学会第135年会
- Place of Presentation
  神戸
- Year and Date
  2015-03-26
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] 病棟薬剤業務への応用と連携を目指した副作用ゲノムマーカーの探索研究　-泌尿器科における実践事例-2015
- Author(s)
  山本和宏
- Organizer
  第25回日本医療薬学会年会
- Place of Presentation
  横浜
- Year and Date
  2015-11-22
- Invited
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] 分子標的治療薬の皮膚障害に及ぼす物理的刺激の影響2015
- Author(s)
  宮庄章嘉，山本和宏，尾藤利憲，錦織千佳子，中川勉，平野剛，平井みどり
- Organizer
  日本薬学会第135年会
- Place of Presentation
  神戸
- Year and Date
  2015-03-26
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] Apoptotic effects of the extracts of Cordyceps militaris via ERK phosphorylation in a renal cell carcinoma cell line.2015
- Author(s)
  Hiroaki Shichiri, Kazuhiro Yamamoto, Tsutomu Nakagawa, Takeshi Hirano, Midori Hirai
- Organizer
  The 3rd International Symposium of Training Plan for Oncology Professionals
- Place of Presentation
  Osaka
- Year and Date
  2015-02-07
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] 分子標的治療薬による皮膚障害の発症メカニズムの解明と副作用バイオマーカーの探索2015
- Author(s)
  山本和宏，平野剛，平井みどり
- Organizer
  第23回クリニカルファーマシーシンポジウム・医療薬学フォーラム2015
- Place of Presentation
  名古屋
- Year and Date
  2015-07-05
- Invited
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] ソラフェニブ・スニチニブによるアポトーシス制御機構を介した皮膚障害発症メカニズムの解明2014
- Author(s)
  山本和宏,水本篤志,西村幸治,宇田篤史,中川勉,久米学,槇本博雄,尾藤利憲,錦織千佳子,平野剛,平井みどり
- Organizer
  日本薬学会134年会
- Place of Presentation
  熊本
- Year and Date
  2014-03-30
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] 冬虫夏草エキスにおけるアポトーシス誘導作用の評価2014
- Author(s)
  七里博章,山本和宏,宇田篤史,中川勉,平野剛,平井みどり
- Organizer
  日本薬学会134年会
- Place of Presentation
  熊本
- Year and Date
  2014-03-30
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] ソラフェニブによる皮膚障害のビタミンC誘導体を用いた予防・治療法のメカニズム解析2014
- Author(s)
  小澤拓,山本和宏,久保萌子,賀来健太,水本篤志,宇田篤史,濱口常男,中川勉,尾藤利憲,錦織千佳子,平野剛,平井みどり
- Organizer
  日本薬学会134年会
- Place of Presentation
  熊本
- Year and Date
  2014-03-30
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] ビタミンC誘導体によるSTAT3の活性化を介した分子標的薬の皮膚毒性軽減効果2014
- Author(s)
  賀来健太，山本和宏，尾藤利憲，錦織千佳子，中川勉，平野剛，平井みどり
- Organizer
  第64回日本薬学会近畿支部総会・大会
- Place of Presentation
  京都
- Year and Date
  2014-10-11
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] MAPK-STAT3解析によるマルチキナーゼ阻害薬治療アルゴリズムの確立2014
- Author(s)
  水本篤志,山本和宏,宇田篤史,高良恒史,中山優子,中川勉,平野剛,平井みどり
- Organizer
  日本薬学会134年会
- Place of Presentation
  熊本
- Year and Date
  2014-03-29
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] 服用後におけるゾピクロン錠(アモバン®錠)とエスゾピクロン錠(ルネスタ®錠)の苦味評価2014
- Author(s)
  宇田篤史,大澤史宜,山本和宏,中川勉,久米学,槇本博雄,平野剛,平井みどり
- Organizer
  日本薬学会134年会
- Place of Presentation
  熊本
- Year and Date
  2014-03-30
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] エベロリムスによるSTAT3活性化変動を介した間質性肺疾患発症機構の探索2014
- Author(s)
  老川諒,山本和宏,宇田篤史,中川勉,平野剛,平井みどり
- Organizer
  日本薬学会134年会
- Place of Presentation
  熊本
- Year and Date
  2014-03-30
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] mTOR阻害薬によるサイトカイン分泌制御を介した口内炎発症機構の解明2014
- Author(s)
  渡邉愛未,山本和宏,宇田篤史,中川勉,平野剛,平井みどり
- Organizer
  日本薬学会134年会
- Place of Presentation
  熊本
- Year and Date
  2014-03-30
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] STAT3遺伝子多型と分子標的治療薬の皮膚障害発症頻度・重症度との関連性2014
- Author(s)
  山本和宏，平田佐智，山口徹郎，須野学，三宅秀明，藤澤正人，尾藤利憲，錦織千佳子，西岡達也，槇本博雄，久米学，中川勉，平野剛，平井みどり
- Organizer
  第24回日本医療薬学会年会
- Place of Presentation
  名古屋
- Year and Date
  2014-09-27
- Data Source
  KAKENHI-PROJECT-26860104
[Presentation] sunitinibによる皮膚障害のバイオマーカー検討2013
- Author(s)
  西村幸治，山本和宏，平野剛，平井みどり
- Organizer
  第63回日本薬学会近畿支部総会・大会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] 分子標的治療薬による皮膚障害のビタミンC誘導体を用いた新規克服法の検討2013
- Author(s)
  賀来健太，山本和宏，宇田篤史，尾藤利憲，錦織千佳子，平野剛，平井みどり
- Organizer
  第63回日本薬学会近畿支部総会・大会
- Place of Presentation
  京都
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] 分子標的治療薬による皮膚障害に対する各種ビタミンを用いた治療への応用2013
- Author(s)
  山本　和宏，西村　幸治，宇田　篤史，向井　啓，山下　和彦，久米　学，槇本　博雄，平野　剛，尾藤　利憲，錦織　千佳子，平井　みどり
- Organizer
  日本薬学会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] sunitinibによる皮膚障害バイオマーカーの検討2013
- Author(s)
  西村幸治,山本和宏,宇田篤史,向井啓,久米学,槇本博雄,平野剛,尾藤利憲,錦織千佳子,平井みどり
- Organizer
  日本薬学会第133年会
- Place of Presentation
  横浜
- Year and Date
  2013-03-30
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] タクロリムス併用腎移植維持期におけるエベロリムス初期投与量の検討2013
- Author(s)
  山本和宏,田中健太,宇田篤史,久米学,槇本博雄,平野剛,平井みどり
- Organizer
  第23回日本医療薬学会年会
- Place of Presentation
  仙台
- Year and Date
  2013-09-22
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] 分子標的治療薬による皮膚障害に対する各種ビタミンを用いた治療への応用2013
- Author(s)
  山本和宏,西村幸治,宇田篤史,向井啓,久米学,槇本博雄,平野剛,尾藤利憲,錦織千佳子,平井みどり
- Organizer
  日本薬学会第133年会
- Place of Presentation
  横浜
- Year and Date
  2013-03-30
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] sunitinib による皮膚障害バイオマーカーの検討2013
- Author(s)
  西村　幸治，山本　和宏，宇田　篤史，向井　啓，久米　学，槇本　博雄，平野　剛，尾藤　利憲，錦織　千佳子，平井　みどり
- Organizer
  日本薬学会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] モルヒネ導入患者における腎機能を考慮した副作用発現頻度の検討2012
- Author(s)
  冨田猛,山本和宏,久米学,槇本博雄,平野剛,平井みどり
- Organizer
  第6回日本緩和医療薬学会年会
- Place of Presentation
  神戸
- Year and Date
  2012-10-02
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] ゾピクロン錠(アモバン錠®)とエスゾピクロン錠(ルネスタ錠®)の苦味評価2012
- Author(s)
  宇田篤史,原口珠実,吉田都,向井啓,山本和宏,久米学,槇本博雄,平野剛,内田享弘,平井みどり
- Organizer
  第22回日本医療薬学会年会
- Place of Presentation
  神戸
- Year and Date
  2012-10-28
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] 分子標的治療薬による皮膚障害の副作用バイオマーカーの探索2012
- Author(s)
  山本　和宏，西村　幸治，宇田　篤史，向井　啓，山下　和彦，久米　学，槇本　博雄，平野　剛，尾藤　利憲，錦織　千佳子，平井　みどり
- Organizer
  日本癌治療学会
- Place of Presentation
  パシフィコ横浜
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] Dimension® Xpandを用いた血清リチウム濃度の院内測定2012
- Author(s)
  若松雄太,山下和彦,山本和宏,向井啓,瀬戸崇光,宇田篤史,平野剛,濱口常男,岩川精吾,太田光熙,棚橋孝雄,平井みどり
- Organizer
  第29回日本TDM学会学術大会
- Place of Presentation
  神戸
- Year and Date
  2012-06-17
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] CLIA法およびACMIA法におけるシクロスポリンA血中濃度測定法の比較2012
- Author(s)
  宮川典子,冨田猛,山本和宏,宇田篤史,向井啓,山下和彦,久米学,槙本博雄,平野剛,平井みどり
- Organizer
  第29回日本TDM学会学術大会
- Place of Presentation
  神戸
- Year and Date
  2012-06-16
- Data Source
  KAKENHI-PROJECT-24790156
[Presentation] 新規mTORC1結合因子P110の栄養感知システムとしての生理機能解析
- Author(s)
  七里博章、山本和宏、中川勉、平野剛、平井みどり
- Organizer
  第37回日本分子生物学会年会
- Place of Presentation
  パシフィコ横浜
- Year and Date
  2014-11-25 – 2014-11-27
- Data Source
  KAKENHI-PROJECT-25460211

1. 座間味義人 (70550250)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
2. 濱野裕章 (10847289)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
3. 小山敏広 (60595106)

# of Collaborated Projects: 2 results

# of Collaborated Products: 0 results
4. HIRANO TAKESHI (00322826)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
5. HIRAI Midori (70228766)

# of Collaborated Projects: 1 results

# of Collaborated Products: 1 results
6. 矢野育子 (50273446)

# of Collaborated Projects: 1 results

# of Collaborated Products: 11 results
7. 新村貴博 (50910014)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
8. 松本准 (60709012)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
9. 武田達明 (20973837)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
10. 上原孝 (00261321)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
11. 細野祥之 (60820363)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results
12. HISHIMOTO Akitoyo

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results
13. 中川勉

# of Collaborated Projects: 0 results

# of Collaborated Products: 7 results
14. 曽良一郎

# of Collaborated Projects: 0 results

# of Collaborated Products: 1 results

Yamamoto Kazuhiro 山本 和宏

YAMAMOTO KAZUHIRO 山本 和宏

Research Projects

Research Products

Co-Researchers

Development of a high-throughput screening method to overcome both drug resistance and adverse effects in cancer pharmacotherapy

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

データベーススクリーニングを活用した慢性腎臓病の新規治療標的の探索Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Prediction of Immune Checkpoint Inhibitor-Induced Myocarditis through Integrated Analysis of Real-World Data and Genomics

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

周産期母児における抗精神病薬治療の適正化のためのファーマコメトリクス

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Strategy for prevention of interstitial lung disease induced by molecular targeted therapy.Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Integrated research for clarification of molecular biological and pharmacogenomic mechanisms of interstitial lung disease induced by molecular targeted drugsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Searching for treatment and prevention method of molecular targeted drugs-induced dermatological side effects based on the pathological mechanismPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

The role of the mTOR signalling pathway in placental nutrient transport.

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

Search for biomarkers of adverse events as skin reaction by molecular target drugsPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Book] 医薬ジャーナル2012年9月号2012

Author(s)

Publisher

Data Source

[Journal Article] Pharmacokinetics of Brexpiprazole, Quetiapine, Risperidone, and Its Active Metabolite Paliperidone in a Postpartum Woman and Her Baby2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Physiologically‐based pharmacokinetic model to investigate the effect of pregnancy on risperidone and paliperidone pharmacokinetics: Application to a pregnant woman and her neonate2023

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Upfront use of first-/second-generation EGFR-TKI followed by osimertinib shows better prognosis than upfront osimertinib therapy in Japanese patients with non-small-cell lung cancer with exon 19 deletion: A single-center retrospective study.2023

Author(s)

Journal Title

Data Source

[Journal Article] ALBI Grade Is a Predictive Factor of Lenvatinib Treatment Discontinuation due to Adverse Events in Hepatocellular Carcinoma2023

Author(s)

Journal Title

Yamamoto Kazuhiro 山本和宏

YAMAMOTO KAZUHIRO 山本和宏